Analysis of purified Wild type and mutant adenovirus particles by SILAC based quantitative proteomics

被引:12
作者
Alqahtani, Ali [1 ,2 ]
Heesom, Kate [3 ]
Bramson, Jonathan L. [4 ]
Curiel, David [5 ,6 ]
Ugai, Hideyo [5 ]
Matthews, David A. [1 ]
机构
[1] Univ Bristol, Sch Cellular & Mol Med, Bristol BS8 1TD, Avon, England
[2] Najran Univ, Coll Appl Med Sci, Najran 1983, Saudi Arabia
[3] Univ Bristol, Fac Med & Vet Sci, Prote Facil, Bristol BS8 1TD, Avon, England
[4] McMaster Univ, McMaster Immunol Res Ctr, Michael DeGroote Ctr Learning & Discovery 4016, Hamilton, ON L8S 4L8, Canada
[5] Washington Univ, Sch Med, Dept Radiat Oncol, Canc Biol Div, St Louis, MO 63108 USA
[6] Washington Univ, Sch Med, Biol Therapeut Ctr, St Louis, MO 63108 USA
基金
英国惠康基金;
关键词
CORE PROTEIN; PURIFICATION; GENE; DNA; PLATFORM;
D O I
10.1099/vir.0.068221-0
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
We used SILAC (stable isotope labelling of amino acids in cell culture) and high-throughput quantitative MS mass spectrometry to analyse the protein composition of highly purified WT wild type adenoviruses, mutant adenoviruses lacking an internal protein component (protein V) and recombinant adenoviruses of the type commonly used in gene therapy, including one virus that had been used in a clinical trial. We found that the viral protein abundance and composition were consistent across all types of virus examined except for the virus lacking protein V, which also had reduced amounts of another viral core protein, protein VII. In all the samples analysed we found no evidence of consistent packaging or contamination with cellular proteins. We believe this technique is a powerful method to analyse the protein composition of this important gene therapy vector and genetically engineered or synthetic virus-like particles. The raw data have been deposited at proteomexchange, identifer PXD001120.
引用
收藏
页码:2504 / 2511
页数:8
相关论文
共 35 条
  • [1] Adenovirus Composition, Proteolysis, and Disassembly Studied by In-depth Qualitative and Quantitative Proteomics
    Benevento, Marco
    Di Palma, Serena
    Snijder, Joost
    Moyer, Crystal L.
    Reddy, Vijay S.
    Nemerow, Glen R.
    Heck, Albert J. R.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (16) : 11421 - 11430
  • [2] DNA-BINDING PROPERTIES OF THE MAJOR CORE PROTEIN OF ADENOVIRUS-2
    BLACK, BC
    CENTER, MS
    [J]. NUCLEIC ACIDS RESEARCH, 1979, 6 (06) : 2339 - 2353
  • [3] HUMAN ADENOVIRUS TYPE-2 PROTEIN-IIIA .2. MATURATION AND ENCAPSIDATION
    BOUDIN, ML
    DHALLUIN, JC
    COUSIN, C
    BOULANGER, P
    [J]. VIROLOGY, 1980, 101 (01) : 144 - 156
  • [4] CHATTERJEE PK, 1985, J VIROL, V55, P379, DOI 10.1128/JVI.55.2.379-386.1985
  • [5] Analysis of the adenovirus type 5 proteome by liquid chromatography and tandem mass spectrometry methods
    Chelius, D
    Hühmer, AFR
    Shieh, CH
    Lehmberg, E
    Traina, JA
    Slattery, TK
    Pungor, E
    [J]. JOURNAL OF PROTEOME RESEARCH, 2002, 1 (06) : 501 - 513
  • [6] Andromeda: A Peptide Search Engine Integrated into the MaxQuant Environment
    Cox, Juergen
    Neuhauser, Nadin
    Michalski, Annette
    Scheltema, Richard A.
    Olsen, Jesper V.
    Mann, Matthias
    [J]. JOURNAL OF PROTEOME RESEARCH, 2011, 10 (04) : 1794 - 1805
  • [7] ADENOVIRUS TYPE-2 ASSEMBLY ANALYZED BY REVERSIBLE CROSSLINKING OF LABILE INTERMEDIATES
    DHALLUIN, JC
    MARTIN, GR
    TORPIER, G
    BOULANGER, PA
    [J]. JOURNAL OF VIROLOGY, 1978, 26 (02) : 357 - 363
  • [8] INTERMEDIATES IN ADENOVIRUS ASSEMBLY
    EDVARDSSON, B
    EVERITT, E
    JORNVALL, H
    PRAGE, L
    PHILIPSON, L
    [J]. JOURNAL OF VIROLOGY, 1976, 19 (02) : 533 - 547
  • [9] Evans VC, 2012, NAT METHODS, V9, P1207, DOI [10.1038/NMETH.2227, 10.1038/nmeth.2227]
  • [10] STRUCTURAL PROTEINS OF ADENOVIRUSES .10. ISOLATION AND TOPOGRAPHY OF LOW-MOLECULAR WEIGHT ANTIGENS FROM VIRION OF ADENOVIRUS TYPE-2
    EVERITT, E
    SUNDQUIST, B
    PETTERSSON, U
    PHILIPSON, L
    [J]. VIROLOGY, 1973, 52 (01) : 130 - 147